Indivior (INDVL)

1,123.00p
   
  • Change Today:
    -0.26p
  • 52 Week High: 1,180.00
  • 52 Week Low: 577.50
  • Currency: UK Pounds
  • Shares Issued: 718.58m
  • Volume: 67,018
  • Market Cap: £8,070m

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

Key Personnel

CEO: Mark Crossley
Chairman: David E. Wheadon
Independent Non-Executive Director: Tony Kingsley
Independent Non-Executive Director: Mark Stejbach
Independent Non-Executive Director: Peter Bains
Independent Non-Executive Director: Joe Ciaffoni
Independent Non-Executive Director: Barbara Ryan
Independent Non-Executive Director: Daniel A. Ninivaggi
Independent Non-Executive Director: Keith Humphreys
Independent Non-Executive Director: Jo Le Couilliard
Senior Independent Director: Juliet Thompson
Non-Executive Dir:

Contact Details

Address: 234 Bath Road, Slough, Berkshire, United Kingdom, SL1 4EE
Website: http://www.Indivior.com

Listings

Overseas Listings: LSE:INDV
ISIN: GB00BRS65X63

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

Indivior Market Data

Currency UK Pounds
Share Price 1,123.00p
Change Today -0.26p
% Change -2.26 %
52 Week High 1,180.00
52 Week Low 577.50
Volume 67,018
Shares Issued 718.58m
Market Cap £8,070m

Trades for 08-Jul-2025

Time Volume / Share Price
16:29 98 @ 1,123.00p
16:29 2 @ 1,122.00p
16:29 5 @ 1,120.00p
16:29 5 @ 1,120.00p
16:29 3 @ 1,120.00p

Indivior Key Personnel

CEO Mark Crossley
Chair David E. Wheadon

Top of Page